Eran E. Bram
Impact in
-
- Drug Transport and Resistance Mechanisms
-
- Epigenetics and DNA Methylation
- Cancer therapeutics and mechanisms
- RNA modifications and cancer
- CRISPR and Genetic Engineering
Papers in
- Oncology 7
- Drug Transport and Resistance Mechanisms 7
-
- Cancer therapeutics and mechanisms 3
- RNA Interference and Gene Delivery 2
- Epigenetics and DNA Methylation 2
- Glycosylation and Glycoproteins Research 1
- RNA modifications and cancer 1
- Co-authors
- Yehuda G. Assaraf (9 shared papers)Michal Stark (3 shared papers)Saurabh K. Gupta (1 shared paper)Ron Weiss (1 shared paper)Shachar Raz (1 shared paper)Andrzej Składanowski (3 shared papers)Ilan Ifergan (3 shared papers)Nitzan Gonen (1 shared paper)
- Journals
- Biochemical Pharmacology (2 papers)Biochemical and Biophysical Research Communications (1 paper)Molecular Pharmacology (1 paper)Cancer Research (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Eran E. Bram
12 papers receiving 693 citations
Peers
Comparison fields: 5 of 84
- Oncology 241
- Molecular Biology 400
- Cancer Research 64
- Physiology 17
- Genetics 93
Countries citing papers authored by Eran E. Bram
This map shows the geographic impact of Eran E. Bram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eran E. Bram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eran E. Bram more than expected).
Fields of papers citing papers by Eran E. Bram
This network shows the impact of papers produced by Eran E. Bram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eran E. Bram. The network helps show where Eran E. Bram may publish in the future.
Co-authors
The 25 scholars most cited alongside Eran E. Bram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 110 | |
| 2 | 2009 | 100 | |
| 3 | 2009 | 94 | |
| 4 | 2012 | 92 | |
| 5 | 2020 | 65 | |
| 6 | 2005 | 52 | |
| 7 | 2010 | 48 | |
| 8 | 2007 | 40 | |
| 9 | 2008 | 37 | |
| 10 | 2006 | 29 | |
| 11 | 2009 | 19 | |
| 12 | 2018 | 13 |
About Eran E. Bram
Eran E. Bram is a scholar working on Oncology, Molecular Biology, Genetics, Endocrinology and Neurology, having authored 12 papers that have together received 699 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (3 papers), RNA Interference and Gene Delivery (2 papers), Epigenetics and DNA Methylation (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Glycosylation and Glycoproteins Research (1 paper), RNA modifications and cancer (1 paper) and Escherichia coli research studies (1 paper). The work is most often cited by research in Oncology (241 citations), Molecular Biology (400 citations), Cancer Research (64 citations), Physiology (17 citations) and Genetics (93 citations). Eran E. Bram has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Yehuda G. Assaraf, Michal Stark, Saurabh K. Gupta, Ron Weiss, Shachar Raz, Andrzej Składanowski, Ilan Ifergan, Nitzan Gonen, Gerrit Jansen and Yael Mandel‐Gutfreund. Their work appears in journals such as Biochemical Pharmacology, Biochemical and Biophysical Research Communications, Molecular Pharmacology, Cancer Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.